Full-Time

Director – Global Regulatory Affairs

Precision Medicine

Posted on 9/4/2024

Telix Pharmaceuticals

Telix Pharmaceuticals

201-500 employees

Develops targeted radiation therapies for cancer

Biotechnology
Healthcare

Senior, Expert

Remote in USA

Category
Risk & Compliance
Legal & Compliance
Medical, Clinical & Veterinary
Requirements
  • Bachelor’s degree required; Advanced degree in life sciences, pharmacy, chemistry, or a related field (Ph.D., Pharm.D., or M.S.) preferred.
  • 10+ years of experience in regulatory affairs, with a strong focus on regulatory strategy for global drug development.
  • Proven track record of successful global regulatory submissions and approvals.
  • In-depth knowledge of global regulatory requirements and guidelines for both small molecule and biologics drug development.
  • Experience in radiopharmaceuticals and/or diagnostics drug products preferred.
  • Experience in leading and managing regulatory teams, with a demonstrated ability to mentor and develop staff.
  • Strong analytical, strategic thinking, and problem-solving skills.
  • Excellent communication and negotiation skills, with the ability to influence and build consensus across diverse teams.
  • Ability to work effectively in a fast-paced, dynamic environment with changing priorities.
  • Experience in regulatory interactions with global health authorities, including FDA and EMA.
  • Proven ability to manage multiple projects and priorities simultaneously.
Responsibilities
  • Lead the development and implementation of global regulatory strategies for small molecule products, from early development through commercialization.
  • Identify and mitigate regulatory risks, ensuring alignment with business objectives and timelines.
  • Provide strategic regulatory guidance to cross-functional teams, including R&D, clinical, manufacturing, and commercial teams.
  • Oversee the preparation, submission, and management of regulatory filings, including INDs, NDAs, BLAs, MAAs, and other global regulatory submissions.
  • Liaise with global health authorities, including the FDA, EMA, and other regulatory bodies, to facilitate product approvals.
  • Ensure timely responses to regulatory inquiries and oversee the negotiation of regulatory pathways.
  • Ensure that all regulatory activities are conducted in compliance with applicable laws, regulations, and guidelines.
  • Monitor the global regulatory environment, assess the impact of new regulations, and communicate changes to relevant stakeholders.
  • Develop and implement regulatory policies, procedures, and best practices.
  • Lead, mentor, and develop a high-performing global regulatory affairs team.
  • Foster a collaborative and innovative team culture, promoting professional growth and continuous learning.
  • Allocate resources effectively to meet project timelines and regulatory goals.
  • Collaborate with internal and external stakeholders, including clinical, manufacturing, legal, and commercial teams, to ensure regulatory alignment.
  • Represent regulatory affairs in senior management meetings and decision-making processes.
  • Build and maintain relationships with key regulatory agencies and external partners.
  • Provide regulatory due diligence and support for business development activities, including mergers and acquisitions, licensing, and partnership opportunities.
  • Assess regulatory risks and opportunities for potential new projects or acquisitions.
Telix Pharmaceuticals

Telix Pharmaceuticals

View

Telix Pharmaceuticals develops and sells products aimed at improving the diagnosis and treatment of cancer and rare diseases. The company focuses on creating therapeutic and diagnostic solutions that use targeted radiation, which helps healthcare providers make better treatment decisions and offers personalized therapy for patients with significant medical needs. Their product pipeline includes treatments for prostate and kidney cancers, glioma, sarcoma, and bone marrow conditioning. Telix operates a global supply chain to manufacture and distribute its products, generating revenue through sales to healthcare institutions. The company emphasizes sustainability, patient care, and ethical practices, aiming to create value for patients, shareholders, and employees.

Company Stage

IPO

Total Funding

$14.8M

Headquarters

Melbourne, Australia

Founded

2015

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of ImaginAb's assets accelerates development of next-generation cancer therapies.
  • New cyclotrons in Brussels enhance production capabilities for radiopharmaceuticals.
  • Expansion of North American network strengthens distribution capabilities in a key market.

What critics are saying

  • Integration challenges with ImaginAb's technology could delay new therapy development.
  • Retirement of co-founder Andreas Kluge may disrupt leadership continuity.
  • Rapid expansion into North America could strain operational resources and pose integration risks.

What makes Telix Pharmaceuticals unique

  • Telix focuses on molecularly-targeted radiation therapy for prostate, renal, and glioblastoma cancers.
  • The company integrates diagnostics and therapy, offering personalized treatment for complex diseases.
  • Telix's global supply chain ensures availability and delivery of specialized products worldwide.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Annual Performance Bonus

Equity-Based Incentive Program

Paid Vacation

Paid Wellness Days

Hybrid Work Options

Remote Work Options

INACTIVE